Literature DB >> 22279140

Mechanisms of action of (n-3) fatty acids.

Philip C Calder1.   

Abstract

(n-3) PUFA are a family of biologically active fatty acids. The simplest member of this family, α-linolenic acid, can be converted to the more biologically active very long-chain (n-3) PUFA EPA and DHA; this process occurs by a series of desaturation and elongation reactions, with stearidonic acid being an intermediate in the pathway. Biological activity of α-linolenic and stearidonic acids most likely relates to their conversion to EPA. The very long-chain (n-3) PUFA have a range of physiological roles that relate to optimal cell membrane structure and optimal cell function and responses. Thus, (n-3) PUFA play a key role in preventing, and perhaps treating, many conditions of poor health and well-being. The multiple actions of (n-3) PUFA appear to involve multiple mechanisms that connect the cell membrane, the cytosol, and the nucleus. For some actions, (n-3) PUFA appear to act via receptors or sensors, so regulating signaling processes that influence patterns of gene expression. Some effects of (n-3) PUFA seem to involve changes in cell membrane fatty acid composition. Changing membrane composition can in turn affect membrane order, formation of lipid rafts, intracellular signaling processes, gene expression, and the production of both lipid and peptide mediators. Under typical Western dietary conditions, human cells tend to have a fairly high content of the (n-6) fatty acid arachidonic acid. Increased oral intake of EPA and DHA modifies the content of arachidonic acid as well as of EPA and DHA. Arachidonic acid is the substrate for eicosanoids involved in physiology and pathophysiology. The eicosanoids produced from EPA frequently have properties that are different from those that are produced from arachidonic acid. EPA and DHA are also substrates for production of resolvins and protectins, which seem to be biologically extremely potent. Increasing the contents of EPA and DHA in membranes modifies the pattern of production of these different lipid mediators.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22279140     DOI: 10.3945/jn.111.155259

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  223 in total

1.  Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB.

Authors:  Nurit Hadad; Rachel Levy
Journal:  Neuromolecular Med       Date:  2017-08-04       Impact factor: 3.843

Review 2.  The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.

Authors:  Gerwyn Morris; Ken Walder; Basant K Puri; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

3.  Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.

Authors:  Kelli A Lytle; Christopher M Depner; Carmen P Wong; Donald B Jump
Journal:  J Lipid Res       Date:  2015-08-27       Impact factor: 5.922

4.  Docosahexaenoic acid regulates the formation of lipid rafts: A unified view from experiment and simulation.

Authors:  Stephen R Wassall; Xiaoling Leng; Samuel W Canner; Edward Ross Pennington; Jacob J Kinnun; Andres T Cavazos; Sahil Dadoo; Dylan Johnson; Frederick A Heberle; John Katsaras; Saame Raza Shaikh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-05-03       Impact factor: 3.747

5.  Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study.

Authors:  Zhan-Yong Chen; Meng Liu; Li-Peng Jing; Mian-Li Xiao; Hong-Li Dong; Geng-Dong Chen; Yu-Ming Chen
Journal:  Eur J Nutr       Date:  2019-04-01       Impact factor: 5.614

Review 6.  Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease.

Authors:  Ashwin N Ananthakrishnan; Hamed Khalili; Gauree G Konijeti; Leslie M Higuchi; Punyanganie de Silva; Charles S Fuchs; Walter C Willett; James M Richter; Andrew T Chan
Journal:  Gut       Date:  2013-07-04       Impact factor: 23.059

7.  Changes of molecular glycerophospholipid species in plasma and red blood cells during docosahexaenoic acid supplementation.

Authors:  Olaf Uhl; Hans Demmelmair; Mario Klingler; Berthold Koletzko
Journal:  Lipids       Date:  2013-09-17       Impact factor: 1.880

8.  Dietary echium oil increases long-chain n-3 PUFAs, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome.

Authors:  Katrin Kuhnt; Claudia Fuhrmann; Melanie Köhler; Michael Kiehntopf; Gerhard Jahreis
Journal:  J Nutr       Date:  2014-02-19       Impact factor: 4.798

9.  Selective identification of specialized pro-resolving lipid mediators from their biosynthetic double di-oxygenation isomers.

Authors:  Trond V Hansen; Jesmond Dalli; Charles N Serhan
Journal:  RSC Adv       Date:  2016-03-04       Impact factor: 3.361

10.  Dietary intake and food sources of total and individual polyunsaturated fatty acids in the Belgian population over 15 years old.

Authors:  Isabelle Sioen; Krishna Vyncke; Mieke De Maeyer; Monique Gerichhausen; Stefaan De Henauw
Journal:  Lipids       Date:  2013-04-16       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.